...
首页> 外文期刊>Journal of the American College of Cardiology >TCT-63 Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries at 24-month follow-up - BIOSOLVE-II and BIOSOLVE-III
【24h】

TCT-63 Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries at 24-month follow-up - BIOSOLVE-II and BIOSOLVE-III

机译:TCT-63药物洗脱吸收金属支架的安全性和临床表现在24个月的后续后续冠状动脉中治疗患有De Novo病变的受试者 - Biosolve-II和Biosolve-III

获取原文
获取原文并翻译 | 示例

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号